Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Randhawa SimratEVP, Head of R&D |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $4.16M 109.0K sh |
| Nov 14, 2025 traded Nov 14, 2025 |
| 22 | Busse BrianGENERAL COUNSEL |  ARLOArlo Technologies, Inc.Open-market sale · 10b5-1 plan | SELL | $2.15M 149.5K sh | Nov 14, 2025 traded Nov 14, 2025 |
| 22 | Pickering EvanGeneral Counsel |  APPFAPPFOLIO INCOpen-market sale · 10b5-1 plan | SELL | $81K 334 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 22 | Gassert ChadSVP - CORP. DEV. & STRATEGY |  ANIPANI PHARMACEUTICALS INCOpen-market sale | SELL | $8,272 94 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 21 | Ferguson Kevin WVP, Controller,Chief Acct.Off. |  SLVMSylvamo CorpOpen-market sale | SELL | $46K 1,000 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 20 | Lampert DarrenDirector, CEO |  GRWGGrowGeneration Corp.Open-market sale | SELL | $91K 56.5K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $485K 3,186 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 |  Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $485K 3,186 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 19 | Randhawa SimratEVP, Head of R&D | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $937K 26.2K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 18 |  Armstrong BrianDirector, Chairman and CEO, 10% Owner |  COINCoinbase Global, Inc.Open-market sale · 10b5-1 plan | SELL | $179K 553 sh | Nov 14, 2025 traded Nov 10, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $136K 868 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $100K 650 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $198K 1,276 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $135K 867 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $237K 1,535 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $198K 1,276 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $237K 1,536 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 16 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $100K 650 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 14 | Greenstreet YvonneDirector, Chief Executive Officer |  ALNYALNYLAM PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $1.11M 2,420 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 14 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $1.55M 3,406 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 13 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $24K 150 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 13 | Farquhar ScottDirector, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $24K 150 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 12 | Ellingson Alan WayneChief Financial Officer |  DKNGDraftKings Inc.Open-market sale · 10b5-1 plan | SELL | $246K 8,421 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 12 | Das SouvikChief Technology Officer |  CWANClearwater Analytics Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $201K 10.0K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 12 | Das SouvikChief Technology Officer | CWANClearwater Analytics Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $203K 10.0K sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $485K 1,069 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $547K 1,210 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $566K 1,255 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $319K 711 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $276K 604 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $891K 1,960 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $958K 2,132 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 11 | Nguyen DianeEVP, Chief Legal Officer & GC |  QBTSD-Wave Quantum Inc.Open-market sale · 10b5-1 plan | SELL | $473K 20.0K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 10 | Cook MeredithSR. VP, GENERAL COUNSEL & SEC. | ANIPANI PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $35K 400 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 9 | Katz ZacharyGC and Head of Global Affairs |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $198K 13.8K sh | Nov 14, 2025 traded Nov 13, 2025 |
| 8 | Meyer Andrew HollmanChief Business Officer |  JANXJanux Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $100K 3,333 sh | Nov 14, 2025 traded Nov 14, 2025 |
| 8 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $197K 430 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 8 | Greenstreet YvonneDirector, Chief Executive Officer | ALNYALNYLAM PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $204K 453 sh | Nov 14, 2025 traded Nov 12, 2025 |
| 8 | Nguyen DianeEVP, Chief Legal Officer & GC | QBTSD-Wave Quantum Inc. Open-market sale · 10b5-1 plan | SELL | $65K 2,803 sh | Nov 14, 2025 traded Nov 13, 2025 |
| 5 | Sroka DianaDirector |  SOUNSOUNDHOUND AI, INC.Open-market sale · 10b5-1 plan | SELL | $17K 1,343 sh | Nov 14, 2025 traded Nov 13, 2025 |